Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $50.51 USD
Change Today +0.01 / 0.02%
Volume 3.5M
ABT On Other Exchanges
Sao Paulo
As of 8:04 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

abbott laboratories (ABT) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/23/15 - $51.74
52 Week Low
10/16/14 - $39.28
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ABBOTT LABORATORIES (ABT)

abbott laboratories (ABT) Details

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices to treat vascular diseases. Abbott Laboratories also offers blood, continuous, and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes under the FreeStyle brand; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. It has strategic alliance with Fonterra. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

73,000 Employees
Last Reported Date: 07/22/15
Founded in 1888

abbott laboratories (ABT) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $2.0M
Executive Vice President of Ventures
Total Annual Compensation: $696.8K
Executive Vice President of Diagnostic Produc...
Total Annual Compensation: $690.0K
Executive Vice President, General Counsel and...
Total Annual Compensation: $650.0K
Executive Vice President of Finance & Adminis...
Total Annual Compensation: $1.0M
Compensation as of Fiscal Year 2014.

abbott laboratories (ABT) Key Developments

Abbott to Invest USD 6.5 Million in Pharmaceutical Centre in Brazil

Abbott announced that the company plans to invest BRL 20 million (USD 6.5 million) to construct a pharmaceutical development centre in Brazil. The new Abbott centre will be located in Rio de Janeiro and its construction will begin in August. Abbott has not confirmed yet which products will be worked on at the unit, but has noted that the pharmaceutical centre will focus on cardiology, neurology, and gastroenterology medicines.

Abbott Laboratories Declares Quarterly Cash Dividend, Payable on August 15, 2015

The board of directors of Abbott declared a quarterly common dividend of 24 cents per share. The cash dividend is payable on Aug. 15, 2015, to shareholders of record at the close of business on July 15, 2015.

Abbott Hit with $15 Million Damages for the Drug was Defectively Designed and Inadequately Tested

Abbott hit with $15 million verdict. A St. Louis jury awarded a Minnesota girl $15 million in damages for birth defects that the jury found were caused by the anti-epileptic drug Depakote her mother took while pregnant. The lawsuit argued Abbott played down the dangers of the Depakote, and that the drug was defectively designed and inadequately tested. The case was tried before St. Louis Circuit Court Judge Steven Ohmer. Te plaintiff, Maddison Schmidt, 12, has numerous birth defects including spina bifida. She is one of two dozen plaintiffs in the suit, including some from the St. Louis area. Attorneys with the Houston law firm Williams Kherkher represented Schmidt. Though Abbott is named in the suit, AbbVie Inc. would be the party that is financially responsible for the verdict. The drug generated $1.5 billion in U.S. sales in 2007 before the patent expired the following year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $50.51 USD +0.01

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,385 GBp +43.00
Danaher Corp $91.76 USD +0.43
Eli Lilly & Co $84.05 USD -0.09
Teva Pharmaceutical Industries Ltd $70.69 USD +0.63
Thermo Fisher Scientific Inc $137.77 USD -0.67
View Industry Companies

Industry Analysis


Industry Average

Valuation ABT Industry Range
Price/Earnings 32.2x
Price/Sales 3.7x
Price/Book 3.4x
Price/Cash Flow 14.7x
TEV/Sales 2.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at